Kenneth C. Cundy, SVP, Preclinical Development at XENOPORT INC (XNPT), sold 2,000 shares at $18.75 ($38K) on 2010-01-04, disclosed to the SEC on 2010-01-06.
Scheduled sale ($38k) by SVP, Preclinical Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.75 | 100 | $2K | 4.9% |
| 2 | $18.78 | 100 | $2K | 4.9% |
| 3 | $18.84 | 100 | $2K | 4.9% |
| 4 | $19.08 | 100 | $2K | 5.0% |
| 5 | $19.14 | 95 | $2K | 4.7% |
| 6 | $19.17 | 5 |
| $96 |
| 0.2% |
| 7 | $19.17 | 100 | $2K | 5.0% |
| 8 | $19.20 | 100 | $2K | 5.0% |
| 9 | $19.22 | 200 | $4K | 10.0% |
| 10 | $19.23 | 100 | $2K | 5.0% |
| 11 | $19.24 | 200 | $4K | 10.0% |
| 12 | $19.25 | 268 | $5K | 13.4% |
| 13 | $19.26 | 32 | $616 | 1.6% |
| 14 | $19.27 | 100 | $2K | 5.0% |
| 15 | $19.28 | 200 | $4K | 10.1% |
| 16 | $19.36 | 100 | $2K | 5.0% |
| 17 | $19.52 | 100 | $2K | 5.1% |
| Total | $19.18 avg | 2,000 | $38K | 100% |
| Filing → |
| CWBR | SELL | 2020-08-10 | $19K | — | Filing → |
| CWBR | SELL | 2020-06-17 | $24K | — | Filing → |
| CWBR | SELL | 2020-05-18 | $26K | — | Filing → |